Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in Poland
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1041
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in Poland ; day:6 ; month:8 ; year:2016 ; pages:1-7
European journal of clinical pharmacology ; (6.8.2016), 1-7
- Creator
-
Stawowczyk, Ewa
- Contributor
-
Kawalec, Paweł
Pilc, Andrzej
SpringerLink (Online service)
- DOI
-
10.1007/s00228-016-2103-4
- URN
-
urn:nbn:de:1111-2016090415089
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Stawowczyk, Ewa
- Kawalec, Paweł
- Pilc, Andrzej
- SpringerLink (Online service)
Other Objects (12)
Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand
Correction to: Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand
A Trial-Based Cost-Utility Analysis of a Medication Optimization Intervention Versus Standard Care in Older Adults
Standards of care in neuromuscular fields
Do transnational corporations care about labour standards?
Do transnational corporations care about labour standards?
Do transnational corporations care about labour standards?
Cost–Utility Analysis of Dapagliflozin as an Add-on to Standard of Care for Patients with Chronic Kidney Disease in Thailand
Revealed Standards for Distributing Public Home-Care on Clients
Pulmonary Metastasectomy for Melanoma: Beyond the Standard of Care
Ovarian cancer standard of care: are there real alternatives?
Clinical Research and Standard of Care — An Unresolved Question?
Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand
Correction to: Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand
A Trial-Based Cost-Utility Analysis of a Medication Optimization Intervention Versus Standard Care in Older Adults
Standards of care in neuromuscular fields
Do transnational corporations care about labour standards?
Do transnational corporations care about labour standards?
Do transnational corporations care about labour standards?
Cost–Utility Analysis of Dapagliflozin as an Add-on to Standard of Care for Patients with Chronic Kidney Disease in Thailand
Revealed Standards for Distributing Public Home-Care on Clients
Pulmonary Metastasectomy for Melanoma: Beyond the Standard of Care
Ovarian cancer standard of care: are there real alternatives?
Clinical Research and Standard of Care — An Unresolved Question?
Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand
Correction to: Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand
A Trial-Based Cost-Utility Analysis of a Medication Optimization Intervention Versus Standard Care in Older Adults
Standards of care in neuromuscular fields
Do transnational corporations care about labour standards?
Do transnational corporations care about labour standards?
Do transnational corporations care about labour standards?
Cost–Utility Analysis of Dapagliflozin as an Add-on to Standard of Care for Patients with Chronic Kidney Disease in Thailand
Revealed Standards for Distributing Public Home-Care on Clients
Pulmonary Metastasectomy for Melanoma: Beyond the Standard of Care
Ovarian cancer standard of care: are there real alternatives?